Targets to Avoid (Or That We Wish We Had)

A discussion with colleagues recently got me to wondering about this useful (albeit grim) question: what area of drug discovery over the last twenty years would you say has taken up the most resources and returned the least value? I'm thinking more of disease/therapeutic areas, but other nominations are welcome, of course. My own candidate is the nuclear receptor field, where some of that time...